Clinical Trial Update: Safety of AM-928 Infusion in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update on the safety of AM-928 infusion in patients with advanced solid tumors; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• AM-928

Snippet

Sponsor: AcadeMab Biomedical Inc. | Conditions: Advanced Solid Tumor | Phase 1 | Status: RECRUITING